About this trial
This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time.
The study will include adults with diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS.
Researchers will study whether glycemic control worsens after surgery and whether this risk changes according to the type of pancreatic resection. The study will also examine changes in glucose metabolism, and cancer-related outcomes.
Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients (≥18 years)
Diabetes mellitus at baseline
Undergoing partial, near-total, or total pancreatectomy at the study center for benign or malignant pancreatic disease
Availability of clinical and metabolic follow-up data according to study component
Disqualifiers
Age <18 years
Absence of diabetes mellitus at baseline
Missing essential clinical data or incomplete follow-up precluding evaluation of study outcomes
Severe pre-existing non-oncologic clinical conditions with life expectancy <6 months
Trial population
Adult patients with diabetes mellitus at baseline undergoing partial, near-total, or total pancreatectomy according to routine clinical practice for benign or malignant pancreatic diseases at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, including retrospective, ambispective, and prospective study components.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Worsening of Glycemic Control After Pancreatectomy
Worsening of glycemic control in participants with diabetes at baseline, defined as HbA1c ≥7.0% within 12 months after surgery according to the type of pancreatic resection.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
European Foundation for the Study of Diabetes
Collaborator
This trial is not recruiting at the moment. You can still explore other options: